Ann: Clinical Trial Contract Expansion & Increases with Bayer AG, page-3

  1. 412 Posts.
    lightbulb Created with Sketch. 143
    I dont think the revenue is that important but the below statement.


    This further contract amendment and expansion with Bayer continues to validate the
    unique capabilities of our FDA-cleared SphygmoCor® technology. Importantly, it is this
    technology - that is trusted by the leading global pharmaceutical companies - that
    forms the basis of our competitive differentiation as we expand into wearables, smart
    home health devices and other new markets”.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $17.94M
Open High Low Value Volume
4.0¢ 4.0¢ 4.0¢ $12.03K 300.7K

Buyers (Bids)

No. Vol. Price($)
1 15000 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 157414 2
View Market Depth
Last trade - 13.15pm 23/06/2025 (20 minute delay) ?
CDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.